Abstract:Background and objectives With increasing life expectancy and prevalence of thalassaemia, it has led to a greater need for safe blood, yet the current supply from voluntary donors is insufficient to meet this demand. Thalassaemia recipients face a significant risk of alloimmunization because of repeated exposure to foreign red cell antigens. Study aims to determine high prevalent Rh antigen negative donors in western India donor population along with what percentage of these donors are willing to become dedicated voluntary donors for thalassaemia patients. Study also aims to examine factors influencing their willingness and challenges faced in mobilizing dedicated donors. Method 700 whole blood donors from western India, following screening for inclusion & exclusion criteria as per Drugs and Cosmetic Act (DCA) 2020 amendment guidelines & were sero-negative for transfusion transmitted infections were enrolled for the study. Red cell phenotyping was performed using Conventional Tube Technique (CTT) for "D", "C", "E", "c", "e" and "K" antigen using known antisera. Donors that were "C" AND/OR "e" antigen negative were contacted telephonically and were counseled and motivated for becoming voluntary blood donors. Statistical analysis assessed correlation between donation frequency, donor's occupation and education. Result: Among 700 donors, 96.6% (n=676) were males and 3.4% (n=24) were females. The most predominant blood group was B > O > A > AB. Rh(D) antigen was present in 91.44% (n = 640) and absent in 8.6% (n=60). Prevalence of other Rh antigens is as follows: "e" (99%) > "C" (85.4%) > "c" (59.1%) > "E" (18.0%). Only 1.15% had "K" antigen positive. The commonest Rh phenotype R 1 R 1 (DCe/DCe) was expressed by 40.57% (n=283), and the least common r"r (cE/ce), r''r''(cE/cE) and r'r' (Ce/Ce) was found in 0.14% (n=1), respectively. 'C' negative, 'e' negative, 'C' and 'e' antigen negative donors constituted 14.8% (n = 104) with 93.2% (n=97) C-antigen negative, 1.92% (n=2) e-antigen negative and 4.8% (n=5) both "C" and "e" antigen negative donors. The commonest phenotypes among C-antigen and e-antigen negative donors were rr (50%) and R z R 2 (1.94%) respectively. Likewise, the most common phenotype amongst both C- and e-antigens negative donors was R 2 R 2 (3.84%). 61.5% of the donors agreed to enroll for voluntary blood donation following telephonic invitation, while 6.8% of them refused permanently. Approximately, 3.9% of the blood donors were willing to donate blood only when needed and 27.8% of them could not be contacted. Conclusion Creating a database of voluntary donors with known phenotype, especially who lack very common antigens like "C" and "e" and are willing to become dedicated, regular voluntary donors for thalassemic patients can ensure timely administration of safe blood. One of the major challenges for this noble initiative was lack of awareness which can be circumvent effectively with proper counseling efforts.

The Incidence of Hepatitis‐Associated Antigen and Antibody in Patients with Thalassaemia in Greece

Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.

HEV Infection in Beta-Thalassemia Patients

Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors

En block resection of a giant gingival malignant melanoma with mandible invasion-a case report

Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: Current prevalence and risk factors

Harnessing the potential of blood donors negative for high prevalence Rh antigens: A Database Initiative for Thalassaemia Care

Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants

The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England

The E3 Ubiquitin Ligase ARIH1 Protects against Genotoxic Stress by Initiating a 4EHP-Mediated mRNA Translation Arrest

[A case of advanced rectal cancer responding to 5-fluorouracil based preoperative chemoradiation therapy].

Evaluation of Transfusion-Related Infections in Patients with Beta Thalassemia Major in Southeast Turkey

Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification

[Spontaneous splenic rupture in acute lymphoblastic leukemia].

Red cell alloantibodies in beta-thalassaemia major patients' blood referring to the regional blood transfusion center of Tehran, Iran

Frequency distribution of HLA class I and II alleles in Greek population and their significance in orchestrating the National Donor Registry Program

Serological detection of hepatitis B virus e antigen and TNF-α in a dialysis patient

Evidence for a cognitive control network for goal-directed attention in simple sustained attention

Anti-HBs Seroprevalence in Blood Donors from Tyrol, Austria

Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project

Identification of Antibody to Low-Frequency Antigen in Thalassemia: Non-specific Allo Adsorption Method